ImmunoPrecise Antibodies (IPA) News Today → This AI made her leave her job (From Prosper Trading Academy) (Ad) Free IPA Stock Alerts $1.03 -0.02 (-1.77%) (As of 03:13 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 12, 2024 | businesswire.comImmunoPrecise Antibodies Ltd. Subsidiary BioStrand Receives Prestigious 2024 Impact Award for Groundbreaking LENSai™ TechnologyJune 10, 2024 | businesswire.comBioStrand, ImmunoPrecise Antibodies' Subsidiary, Announces Immediate Commercial Offering of Groundbreaking Software with Customizable Interface for AI-Driven Drug DiscoveryJune 10, 2024 | americanbankingnews.comImmunoPrecise Antibodies (NASDAQ:IPA) and Bioxytran (OTCMKTS:BIXT) Critical SurveyJune 4, 2024 | businesswire.comIPA's Subsidiary, BioStrand, Announces Advanced Large Language Model (LLM) for Electronic Health Records (EHR)April 26, 2024 | finance.yahoo.comImmunoPrecise Antibodies Ltd. (IPA)March 28, 2024 | finance.yahoo.comInterSystems and IPA’s Subsidiary BioStrand Collaborate to Unveil the Innovative Integration of Vector Search with LENSai for AI-Driven Healthcare ApplicationsMarch 28, 2024 | businesswire.comInterSystems and IPA's Subsidiary BioStrand Collaborate to Unveil the Innovative Integration of Vector Search with LENSai for AI-Driven Healthcare ApplicationsMarch 20, 2024 | businesswire.comIPA Acquires the Carterra LSA® Instrument to Enhance Antibody Discovery and Bolster Its AI DevelopmentsMarch 15, 2024 | msn.comImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2024 Earnings Call TranscriptMarch 14, 2024 | investorplace.comIPA Stock Earnings: ImmunoPrecise Antibodies Misses EPS, Beats Revenue for Q3 2024March 7, 2024 | finance.yahoo.comIPA’s subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing LLM Stacking and HYFT TechnologyMarch 7, 2024 | businesswire.comIPA's subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing LLM Stacking and HYFT TechnologyMarch 4, 2024 | finance.yahoo.comIPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024 on March 14, 2024February 10, 2024 | marketbeat.comImmunoPrecise Antibodies (NASDAQ:IPA) Shares Down 2.3% ImmunoPrecise Antibodies (NASDAQ:IPA) Trading Down 2.3%December 16, 2023 | markets.businessinsider.comBuy Rating on ImmunoPrecise Antibodies Reflects Strong Revenue Growth and Cost Management SuccessDecember 8, 2023 | finance.yahoo.comIPA Announces Closing of $1.265 Million Public Offering of Common SharesDecember 6, 2023 | benzinga.comWhy ImmunoPrecise Antibodies (IPA) Stock Is Down 20% TodayDecember 6, 2023 | investorplace.comWhy Is ImmunoPrecise Antibodies (IPA) Stock Down 39% Today?December 6, 2023 | finance.yahoo.comIPA Announces Pricing of $1.1 Million Public Offering of Common SharesDecember 5, 2023 | investing.comAfter-hours movers: SentinelOne up on earnings, MongoDB sees 'sell the news' reactionDecember 5, 2023 | finance.yahoo.comIPA Announces Proposed Public Offering of Common SharesNovember 27, 2023 | businesswire.comImmunoPrecise Antibodies Ltd. Announces Key Board and Board Committee Chair Appointments and Second Quarter 2024 Earnings Release CallNovember 22, 2023 | finance.yahoo.comImmunoPrecise’s BioStrand(R) Unifies Diverse Data Modalities, Launches AI-Driven Platform For Enhanced Drug DiscoveryNovember 20, 2023 | benzinga.comImmunoPrecise's BioStrand® Unifies Diverse Data Modalities, Launches AI-Driven Platform For Enhanced Drug DiscoveryOctober 25, 2023 | stockhouse.comIPA's Subsidiary, BioStrand, Provides an Update on LENSai(TM)October 25, 2023 | benzinga.comIPA's Subsidiary, BioStrand, Provides an Update on LENSai™October 25, 2023 | financialpost.comIPA’s Subsidiary, BioStrand, Provides an Update on LENSai™October 20, 2023 | finance.yahoo.comOvercoming the Information Integration Dilemma: Revolutionizing The Fusion Of Complex Biological DataOctober 20, 2023 | finance.yahoo.comHow ImmunoPrecise Antibodies Is Leveraging AI To Revolutionize Antibody ResearchSeptember 19, 2023 | finance.yahoo.comImmunoPrecise Antibodies Announces CFO TransitionSeptember 18, 2023 | nasdaq.comHC Wainwright & Co. Reiterates ImmunoPrecise Antibodies (IPA) Buy RecommendationSeptember 18, 2023 | markets.businessinsider.comImmunoPrecise Antibodies (IPA) Receives a Buy from H.C. WainwrightSeptember 17, 2023 | finance.yahoo.comImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q1 2024 Earnings Call TranscriptSeptember 5, 2023 | finance.yahoo.comIPA Announces Board RefreshmentAugust 9, 2023 | finance.yahoo.comIPA Responds to 13D FilingJuly 7, 2023 | finance.yahoo.comImmunoPrecise Reports Financial Results and Recent Business Highlights for Full Fiscal Year 2023July 6, 2023 | msn.comImmunoPrecise Antibodies's Earnings OutlookJune 29, 2023 | finance.yahoo.comIPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Fiscal Year End 2023 on July 7th, 2023.May 30, 2023 | finance.yahoo.comIPA's Subsidiary, BioStrand, Solves the Information Integration Dilemma (IID) for Systems BiologyMay 17, 2023 | finance.yahoo.comIPA to Present at Jefferies Healthcare Conference 2023April 18, 2023 | benzinga.comTheStreetReports: Disruptive Technology Stocks in Focus – KAVL, SONM, PBTS, IPAMarch 30, 2023 | finance.yahoo.comImmunoPrecise’s Subsidiary Talem Enters into Exclusive Research Collaboration and License Option Agreement with AstellasMarch 29, 2023 | stockhouse.comEuropean Patent Office to Grant BioKey's Patent Application for Foundational HYFT® TechnologyMarch 27, 2023 | finance.yahoo.comEuropean Patent Office to Grant BioKey’s Patent Application for Foundational HYFT® TechnologyMarch 23, 2023 | finance.yahoo.comImmunoPrecise Presents Novel T-Cell Engaging Bispecific Antibodies Addressing a Unique Oncological Target, Tropomyosin Receptor Kinase B, Associated with Poor Prognosis and Survival RatesMarch 15, 2023 | finance.yahoo.comImmunoPrecise Antibodies’ Subsidiary Talem Therapeutics Announces a Multi-Target AI-Driven Antibody Discovery Collaboration with Libera BioMarch 7, 2023 | finance.yahoo.comIPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2023 on March 16, 2023December 22, 2022 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Rigel (RIGL), ImmunoPrecise Antibodies (IPA)December 8, 2022 | finance.yahoo.comIPA’s Subsidiary BioStrand Completes Integration of 20 Million Proprietary Structural HYFTs™ and Accelerates in Silico Drug Discovery DevelopmentsDecember 5, 2022 | finance.yahoo.comIPA to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2023 on December 15, 2022 Get ImmunoPrecise Antibodies News Delivered to You Automatically Sign up to receive the latest news and ratings for IPA and its competitors with MarketBeat's FREE daily newsletter. Email Address This AI made her leave her job (Ad)This AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and finds hot stocks that you probably have never even heard of… …it recommends the best potential strategy to use on the names it finds (with historical data to prove it) Click Here To Read More About This Game Changing AI Tool IPA Media Mentions By Week IPA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IPA News Sentiment▼0.430.92▲Average Medical News Sentiment IPA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IPA Articles This Week▼30▲IPA Articles Average Week Get ImmunoPrecise Antibodies News Delivered to You Automatically Sign up to receive the latest news and ratings for IPA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Adicet Bio News Assertio News Connect Biopharma News Tiziana Life Sciences News Vistagen Therapeutics News PDS Biotechnology News Affimed News DiaMedica Therapeutics News LifeVantage News Clearside Biomedical News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IPA) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThis AI made her leave her jobThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredBiden out June 13; replacement chosen?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | SponsoredHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | Sponsored